Evaluation of minimal residual disease by interphase FISH in multiple myeloma: Does complete remission exist?

Leukemia

Volumn 13, Issue 4, 1999, Pages 641-644

  Genevieve, F ^a   Zandecki, M ^a   Lai J L ^b   Hennache, B ^c   Faucompre, J L ^c   Stalnikiewicz, L ^d   Bauters, F ^d   Facon, T ^d  

^a Dept d'Anesthesie Reanimation II   (France)

^b HÔpital Jeanne de Flandre   (France)

^c Laboratoire de biochimie   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Autologous stem cell transplantation; Complete remission; Cytogenetics; Fluorescence in situ hybridization; Multiple myeloma; Plasma cells

Indexed keywords

ANTIBODY; AVIDIN; MELPHALAN;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER REGRESSION; CLINICAL ARTICLE; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL;

EID: 0032958235     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401348     Document Type: Article

References (16)

1. Attal M, Harrouseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R. A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New Engl J Med 1996; 335: 91-97.
2. Zandecki M, Laï JL, Facon T. Multiple myeloma: almost all patients are cytogenetically abnormal. Br J Haematol 1996; 94: 217-227.
3. Flactif M, Zandecki M, Laï JL, Bernardi F, Obein V, Bauters F, Facon T. Interphase fluorescence in situ hyridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma. Leukemia 1995; 9: 2109-2114.
4. Zandecki M, Obein V, Bernardi F, Soenen V, Flactif M, Laï JL, François M, Facon T. Monoclonal gammopathy of undetermined significance: chromosome changes are a common finding within plasma cells. Br J Haematol 1995; 90: 693-696.
5. Zandecki M, Bernardi F, Genevieve F, Laï JL, Preudhomme C, Flactif M, Cosson A, Bauters F, Facon T. Involvement of peripheral blood cells in multiple myeloma: chromosome changes are the rule within circulating plasma cells but not within B lymphocytes. Leukemia 1997; 11: 1034-1039.
6. Durie BGM. Staging and kinetics of multiple myeloma. In: Wiernik PH, Canellos GP, Kyle RA, Schiffer CA (eds). Neoplastic Diseases of the Blood. Churchill Livingstone: New York, 1991, pp 439-451.
7. Durie BGM, Salmon SE. A clinical staging system of multiple myeloma. Correlation of measured myeloma cells mass with presenting clinical features, response to treatment and survival. Cancer 1975; 36: 842-854.
8. Laï JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T. Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 at diagnosis. Blood 1995; 85: 2490-2497.
9. Heerema NA, Argyropoulos G, Weetman R, Tricot G, Secker-Walker LM. Interphase in situ hybridization, reveals minimal residual disease in early remission and return of the diagnostic clone in karyotypically normal relapse of acute lymphoblastic leukemia. Leukemia 1993; 7: 537-543.
10. Nylund SJ, Ruutu T, Saarinen U, Larramendy ML, Knuutila S. Detection of minimal residual disease using fluorescence DNA in situ hybridization: a follow-up study in leukemia and lymphoma patients. Leukemia 1994; 8: 587-594.
11. El-Rifai W, Ruutu T, Vettenranta K, Ebnen F, Saarinen UM, Volin L, Knuutila S. Follow-up residual disease using metaphase-FISH in patients with acute lymphoblastic leukemia in remission. Leukemia 1997; 11: 633-638.
12. Tanaka K, Arif M, Eguchi M, Kumaravel TS, Ueda R, Ohno R, Iwato K, Kyo T, Dohy H, Kamada N. Application of fluorescence in situ hybridization to detect residual leukemic cells with (9;22) and (15;17) translocations. Leukemia 1997; 11: 436-440.
13. Kasprzyk A, Secker-Walker LM. Increased sensitivity of minimal residual disease detection by interphase FISH in acute lymphoblastic leukemia with hyperdiploidy. Leukemia 1997; 11: 429-435.
14. Dascalescu CM, Carban F, Molina L, Cousin F, Marais D, Sotto JJ, Leroux D. Interphase FISH: a simple method for monitoring minimal residual disease in multiple myeloma. Bone Marrow Transplant 1998; 21: S181 (abstr).
15. Corradini P, Voena C, Tarella C, Astolfi M, Ladetto M, Palumbo A, Santoro A, Bacigalupo A, Majolino L, Boccadoro M, Pileri A. Molecular and clinical remissions in multiple myeloma: the role of auto/allografting of haematopoietic cells. Bone Marrow Transplant 1998; 21: S206 (Abstr).
16. Durie BGM. Cellular and molecular genetic features of myeloma and related disorders. In: Hematology/Oncology Clinics of North America, WB Saunders Company: Philadelphia, 1992, pp 463-477.